Combination of a selective noradrenaline reuptake inhibitor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5375 (2006.01) A61K 31/519 (2006.01) A61P 25/02 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2575980

The present invention relates to a combination of a selective noradrenaline reuptake inhibitor (NRI) and a phosphodiesterase type 5 (PDEV) inhibitor. Such a combination is particularly useful in the treatment of pain.

La présente invention concerne une association d'un inhibiteur sélectif de la recapture de la noradrénaline (IRN) et d'un inhibiteur de la phosphodiestérase de type 5 (PDEV). Une telle association est particulièrement utile dans le traitement de la douleur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of a selective noradrenaline reuptake inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of a selective noradrenaline reuptake inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a selective noradrenaline reuptake inhibitor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1652679

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.